Research & Development
Driven by a desire for continuous technological advances with our products, we constantly invest in research and development in order to ensure that the best therapy treatments are available to you. Thanks to close collaboration with various partners, we’re able to advance numerous projects to improve patient treatment options.
Current projects in the pipeline
We methodically and carefully develop all of our research projects in order to ensure an outcome that is in line with corporate standards. We invest more than 10% of our total turnover into research and development and Basic Science Research every year. Once the development path has been outlined, when necessary, we support the project’s start-up with partner research or fundraising activities (phase 2). The project’s engineering process involves two phases, an initial technical and documentation development phase (phase 3) and a second verification and validation phase (validation and release testing – phase 4) in-vitro and/or in vivo. Generally, during this phase we will draft protocol for clinical investigation in order to certify the labelling of the DM (phase 6), before proceeding with the introduction phase (initially controlled - phase 7 and then global – phase 8) on the market.